ProDeg™ Enzalutamide, Target protein ligand (Protein Degrader) (CAT#: PRLG-008)
Please feel free to contact us for a quote and further discussion with our scientists.
Datasheets
| Specifications |
|---|
| Product Description |
Enzalutamide is a second-generation androgen receptor antagonist that binds to the ligand-binding domain of AR with high affinity, blocking nuclear translocation and DNA binding. It is a widely used warhead for bifunctional molecules targeting AR for proteasomal degradation. |
| Molecular Formula |
C21H16F4N4O2S |
| Molecular Weight (Da) |
464.4 |
| Chemical Name |
4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide |
| Chemical Structure |
 |
| Purity |
0.99 |
| Size |
5 mg |
| Physical State |
Powder |
| Storage |
The power can be stored at 4 °C for 2 years or at -20 °C for 3 years. |
| Target Information |
|---|
| Target Name |
AR |
| Alternative Names |
AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM |
| Introduction |
AR is a nuclear receptor transcription factor containing an N-terminal transactivation domain, a central DNA-binding domain with two zinc fingers, and a C-terminal ligand-binding domain. Upon androgen binding, it translocates to the nucleus and regulates target gene expression. |
| Gene ID |
367 |
| UniProt ID |
P10275 |
| Related Disease |
Prostate cancer, androgen insensitivity syndrome, spinal bulbar muscular atrophy |
Our services are For Research Use Only. We do not provide direct services for patients.
